Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $0.28 in the prior trading day, Co-Diagnostics Inc (NASDAQ: CODX) closed at $0.26, down -6.13%. In other words, the price has decreased by -$6.13 from its previous closing price. On the day, 1.09 million shares were traded. CODX stock price reached its highest trading level at $0.2833 during the session, while it also had its lowest trading level at $0.2572.
Ratios:
Our goal is to gain a better understanding of CODX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.23 and its Current Ratio is at 4.43. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 8782107 and an Enterprise Value of -10765659. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.42 while its Price-to-Book (P/B) ratio in mrq is 0.18. Its current Enterprise Value per Revenue stands at -3.078 whereas that against EBITDA is 0.291.
Stock Price History:
The Beta on a monthly basis for CODX is 0.53, which has changed by -0.7730435 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $2.23, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is -5.15%, while the 200-Day Moving Average is calculated to be -57.62%.
Shares Statistics:
The stock has traded on average 763.65K shares per day over the past 3-months and 1030120 shares per day over the last 10 days, according to various share statistics. A total of 33.57M shares are outstanding, with a floating share count of 30.68M. Insiders hold about 9.00% of the company’s shares, while institutions hold 17.48% stake in the company. Shares short for CODX as of 1752537600 were 844026 with a Short Ratio of 1.11, compared to 1749772800 on 282095. Therefore, it implies a Short% of Shares Outstanding of 844026 and a Short% of Float of 2.7199999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Co-Diagnostics Inc (CODX) in the stock market.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.68 and -$0.68 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.34, with 1.0 analysts recommending between -$0.34 and -$0.34.
Revenue Estimates
1 analysts predict $300k in revenue for the current quarter. It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, Co-Diagnostics Inc’s year-ago sales were $2.66MFor the next quarter, 1 analysts are estimating revenue of $300k. There is a high estimate of $300k for the next quarter, whereas the lowest estimate is $300k.
A total of 1 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $950k, while the lowest revenue estimate was $950k, resulting in an average revenue estimate of $950k. In the same quarter a year ago, actual revenue was $3.92M
